531569 Stock Overview
Operates as a pharmaceutical company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Sanjivani Paranteral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹289.85 |
| 52 Week High | ₹360.60 |
| 52 Week Low | ₹122.15 |
| Beta | -0.45 |
| 11 Month Change | 9.34% |
| 3 Month Change | 1.06% |
| 1 Year Change | 106.67% |
| 33 Year Change | 1,014.81% |
| 5 Year Change | 3,387.97% |
| Change since IPO | 751.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531569 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.0% | 0.5% | 0.5% |
| 1Y | 106.7% | 42.5% | 27.5% |
Return vs Industry: 531569 exceeded the Indian Pharmaceuticals industry which returned 42.5% over the past year.
Return vs Market: 531569 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 531569 volatility | |
|---|---|
| 531569 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 531569 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 531569's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 33 | Ashwani Khemka | www.sanjivani.co.in |
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. It manufactures pharmaceutical products in a form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas comprising central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, topicals, nasal sprays, liquid injection, capsules, tablets, dry syrups, and ear/eye drops.
Sanjivani Paranteral Limited Fundamentals Summary
| 531569 fundamental statistics | |
|---|---|
| Market cap | ₹3.39b |
| Earnings (TTM) | ₹69.19m |
| Revenue (TTM) | ₹623.95m |
48.9x
P/E Ratio5.4x
P/S RatioIs 531569 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531569 income statement (TTM) | |
|---|---|
| Revenue | ₹623.95m |
| Cost of Revenue | ₹343.64m |
| Gross Profit | ₹280.31m |
| Other Expenses | ₹211.12m |
| Earnings | ₹69.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.92 |
| Gross Margin | 44.92% |
| Net Profit Margin | 11.09% |
| Debt/Equity Ratio | 22.6% |
How did 531569 perform over the long term?
See historical performance and comparison